Present Your Research at RDD Europe 2025
The Poster Session at RDD Europe 2025 presents research on all aspects of pulmonary and nasal delivery. The abstract submission deadline was January 24, 2025 and the submission portal is now closed. Posters will be presented in Lisbon as a traditional poster augmented by a ten-minute recorded presentation for on-demand viewing.
Accepted abstracts will be published in the Conference Proceedings available to all conference delegates, and those from graduate students will be automatically eligible for the VCU RDD Peter R. Byron Graduate Student Award. The award covers registration fee, travel expenses and accommodation up to a maximum of $2000.
Posters on the Podium will showcase editor-selected posters during a series of ten-minute live presentations in the main auditorium followed by a fast-paced Q&A session. All poster abstracts and on-demand presentations will be featured in online Knowledge Spaces.
Registration fees will be waived for up to 20 graduate students (no more than 2 per advisor) with an accepted poster abstract if their academic advisor is registered to attend at the discounted academic rate of €995. It is expected that the graduate student (not their academic or industrial advisor) will present the poster in Lisbon. By waiving the registration fee, we hope to encourage young scientists to attend RDD, where they'll receive expert feedback on their work, hear the latest from opinion leaders, and network with peers, collaborators and future employers.
When and Where?
Posters will be continuously accessible to in-person delegates from 9:30 AM to 6:00 PM on Wednesday, May 7, 8:30 AM to 6:00 PM on Thursday, May 8, and 8:30 AM to 12:30 PM on Friday, May 9. The Poster and Exhibition Session will be the only RDD event during the following times:
- Wednesday, May 7, 12:00-2:00 PM
- Thursday, May 8, 12:00-2:00 PM
Posters, exhibit tables, meals and refreshment breaks will share an expansive space to maximize interactivity.
On-Demand Narrated Presentations Guidelines - Deadline April 11, 2025
All conference participants want to see your research but may not have time to view all posters in Estoril. We therefore ask presenters to create a compelling 10-minute narrated slide presentation that gives delegates a good appreciation of your work wherever they are. The RDD audience is familiar with many aspects of nasal and pulmonary delivery so keep the background short. Focus on clearly presenting data and conclusions in your abstract. Ensure all claims, especially those that mention competitors, are supported by data or references. Do not include wildly speculative or unsubstantiated comments.
Approximately 8 slides should first be prepared using PowerPoint before using the recording function to add your voice-over narration. Presentations that exceed 10 minutes may end abruptly once posted on our platform. Practice your timing before making your final recording.
Slide Preparation
Step 1. Make slides in 16 x 9 format.
- Slide 1: Presentation title (exactly the same as your poster abstract), names of all presenters and their institution(s). Optionally, include contact information and the presenter's photo. Please note that you are consenting to this information being visible to delegates on all RDD websites when you send us your slides.
- Slide 2: Background/Introduction
- Additional 1 or 2 Slides: Outline your methods, technology or service
- Additional 3 or 4 Slides: Describe your data and insights and highlight their significance
- Avoid complex backgrounds, logos or slide designs which take up too much room and detract from the information you are presenting. Some delegates may watch your presentation on a small screen.
- Use plain fonts such as Arial and ensure text is legible on a tablet or monitor. Use the largest font possible for maximum visibility (no smaller than 18 point is recommended).
- Ensure the axes on graphs are clearly labelled. Thicken lines and use highly visible colors and/or symbols to differentiate among data sets. Provide a key. Do not include graphic elements you will not discuss.
- Figures and photographs should be clearly visible.
- Avoid ‘busy’ slides packed with text or numbers. Instead stick to a few key points.
Step 2. Add your voice-over narration. This How-To-Video supplements the summary below. Please practice your timing before recording your presentation.
- Prepare to record in a quiet location.
- Open the presentation and click the Slide Show tab.
- Check your microphone is set up correctly. A headset generally produces the best quality audio.
- Select the slide where you want the recording to begin then click Record Slide Show and start talking.
- Click End Show to stop recording.
- A Save dialog box appears. Click Yes to save your recording, or No, if you want to record it again. Saving overwrites anything you've previously recorded. It is possible to re-record individual slides.
- Click Play from Start to preview or review your recording.
Step 3. Submit your file.
Send your final PowerPoint (.pptx) file to info@rddonline.com before April 11, 2025.
Send your final PowerPoint (.pptx) file
If the file is too large to e-mail, your organization may have a preferred file transfer protocol (FTP), but if not, we recommend using wetransfer.com.
Preparing and Displaying a Poster
Posters give you the opportunity to display innovative research and technology and interact face-to-face with conference delegates. You are also strongly encouraged to prepare an on-demand recorded presentation in order to share your work with all delegates. These will be posted in the appropriate Knowledge Space through June 30 (see On-Demand Narrated Presentation Guidelines). Taking this extra step allows all delegates to ask you questions using Messaging and means you are ready if invited to participate in Posters on the Podium.
Poster Boards
- We will assign a display location with the dimensions shown in the diagram:
- Maximum Poster Height: 118 cm (1.18 meters)
- Maximum Poster Width: 136 cm (1.36 meters)
- Your poster can be attached to the board with adhesive pads, which we will supply at the conference.
- There will not be a table below the poster board.
- Posters do not have access to electricity.
Making an Impact
Posters provoke the most discussion when you follow three simple rules:
- Make the text large and legible. We recommend a dark-colored font, readable at six feet.
- Focus on one or two essential themes and emphasize novel findings.
- Keep the overall design simple, but include legible diagrams, tables, and figures.
If you need to ship your poster rather than hand-carry, see Shipping Instructions posted on our website.
Poster Session Etiquette
Poster content must be closely related to your published abstract. All claims and conclusions must be supported by data or references. Do not include speculative or unsubstantiated comments.
The major attraction of a poster is you, the presenter. Please be present at your poster to answer questions for at least an hour each time the Poster Session is open. If you don’t plan to stay at your poster the whole time, it’s helpful to display a sign showing the times you plan to be present.
Poster Set-up and Take-down
- Set-up is encouraged on Tuesday, May 6, between 3:00 PM–6:00 PM. Please visit the Registration Desk, review the conference program for the floor plan to find your assigned poster location. Do not set up in a different location. Late arrivals may set up on Wednesday, May 7, from 7:30 to 8:30 AM.
- We recommend that you take small, high-value items such as laptops and prototype devices with you when you are not at your poster or when leaving the space for the evening.
- A Poster and Exhibition Floor Plan will be provided to all delegates.
- Posters must be removed by 2:00 PM on Friday, May 9.
The meeting organizers and the Estoril Congress Center expressly disclaim responsibility for loss or damage to any items you bring into the Poster and Exhibition space.
Shipping Instructions
Please ensure anyone shipping packages to the conference on your behalf receives a copy of these instructions.
Rangel (Storage Center) is responsible for receiving your shipment and transporting it to the Estoril Congress Center
Shipping & Receiving Contact Information: Helder Marques
Email: helder.marques@rangel.com
Phone: +351 967 364 259
Incoming Shipping Schedule
Shipments should be timed to arrive between Monday, April 21 and Friday, May 2, 2025. Please allow sufficient time for customs clearance. RDD Europe 2025 cannot accept responsibility for lost, damaged or delayed shipments or customs clearance and will not pay COD or customs charges. Packages will be brought to your exhibit table or poster by conference staff.
Labeling your Incoming Shipment
Please attach Main and Auxiliary Shipping Labels, containing the indicated information.

General Guidelines for Incoming Shipments
You and your shipper are responsible for getting your shipment to Rangel. The following suggestions are based on past experience and are offered only as a guide and may not be relevant to all shipments.
- All shipments are subject to inspection. Please allow time for customs clearance in Portugal.
- Consider including “Items for trade demonstration and re-export” on the Auxiliary Shipping Label and documentation, where appropriate.
- Rangel advise that imports to Portugal must display a valid EORI or VAT (VIES) number to allow definitive or temporary customs clearance. These numbers must be be displayed on the auxiliary label and documentation. Contact Rangel if you have customs questions.
- Transport and custom charges are the responsibility of the sender. Neither Rangel nor the Congress Center will pay these. Please ensure that all transport and customs fees are prepaid.
- Package fragile equipment carefully. Dangerous or suspicious looking items should not be shipped to RDD Europe 2025.
- Ensure that your return address or that of your shipping company is clearly displayed on the outer box.
Outgoing Shipments
- You are responsible for packing your outgoing shipment. The Congress Center does not have packaging facilities. Remember to include packaging materials, a roll of tape and scissors in your incoming shipment.
- You are responsible for shipping items after the conference. Please contact your carrier (DHL, Fedex, UPS, etc.) to obtain the appropriate forms and labels, and consider including pre-completed forms in your incoming shipment. It may also be necessary to arrange pick-up by your carrier.
- You are welcome to use the Congress Center’s loading dock to facilitate larger outgoing shipments. Your shipper should pick up your items between 2:00 pm to 8:00 pm on Friday, May 9. The pick-up address is:
Estoril Centro de Congressos
Av Amaral
2765-192 Estoril PORTUGAL
Outgoing Shipment Questions?
Contact: Wagner Câmara, Event Coordinator
Tel: (+351) 214 647 571
Email: wagner.camara@estorilcc.com
Poster Presentations
Aptar Digital Health
Akash Bijlani
Impact of a Digital Health Respiratory Disease Management Platform on Adult AsthmaGoncalo Farias
Meta Analysis of Variables Affecting Nasal Spray Product Actuation Force ProfileKarl Bass
Mapping the Product Design Space: Understanding and Controlling Manufacturing Variability in Pressurized Metered Dose InhalersLei Mao and Ross Errington
Development of Albuterol Sulfate pMDI using a Low Global Warming Potential Propellant 1,3,3,3-Tetrafluoropropene (HFO-1234ze) to Match Ventolin® HFA Inhaler: I. Formulation, Container Closure System and Actuator Selection ConsiderationsLei Mao and Ross Errington
Development of Albuterol Sulfate pMDI Using a Low Global Warming Potential Propellant 1,3,3,3-Tetrafluoropropene (HFO-1234ze) to Match Ventolin® HFA Inhaler: II. Human Factors Engineering ConsiderationsCambridge Healthcare Innovations
Heather Jameson
High Delivered Dose in a Single Inhalation for Carrier-Based Formulations by Retaining Carrier-Fraction in Dry Powder Inhaler BlisterMichael Vernizzi
Formulation Study on siRNA-LNP Embedded in an Inhalable Freeze-Dried Matrix for Lung TargetingChiesi Limited
Cristina Rey Blanes
Further Exploration on the Manufacturing Repeatability and the Interaction Between Blending Parameters of Dry Powder Blends Produced by Resonant Acoustic MixingRoss Blezard
Impact of Lactose Carrier Morphology and Amorphicity on the Aerosol Performance of Fluticasone Propionate Dry Powder InhalersFederation University
Rob Bischof
Poly (ADP-Ribose) Polymerase Inhibition as a Treatment Option for Pulmonary FibrosisAna Costa and Hosein Sadafi
Validation of Lung Deposition of Fluticasone Propionate/Formoterol Fumarate in Chronic Obstructive Pulmonary Disease Patients Using Functional Respiratory ImagingNavid Monshi Tousi and Hosein Sadafi
Impact of Anatomical Variability on Nasal Deposition in Pediatric Subjects of the Same Age and GenderHosein Sadafi
From Healthy to Diseased: Evaluating Bioequivalence in Orally Inhaled Drug DeliveryHosein Sadafi
Sensitivity Analysis of Inhaled Drug Deposition Delivered via Metered Dose Inhalers in Chronic Obstructive Pulmonary Disease PatientsAmeet Sule
Investigation of In Vitro Techniques for Evaluating Ipratropium Bromide FormulationsGregory Smith
Performance Comparison of Beclomethasone, Formoterol, and Glycopyrronium Solution Formulations in HFO-1234ze(E) to Reference Listed DrugsRui Churro
Advancing High-Dosage Dry Powder Inhaler Formulations: Integrating Quality By Design For Optimized PerformanceClaudia Costa
Characterization Study of Nasal Deposition Targeting the Central Nervous SystemLuis Marques
Optimizing Monoclonal Antibody Delivery: Transitioning Between Nebulization and Spray-dried PowdersAlexandre Ribeiro and Mykaella Mestre
Distinct Baseline Phenotypical and Functional Properties of Macrophages Derived from Two Different Lots of THP-1 Monocytes for Screening the Effects of Inhalable DrugsMark Parry
Aerosolization of Wegovy® and Prototype Formulations of Semaglutide with the MRX004 Soft Mist InhalerAnna Vivani
Preliminary Development of a Nanostructured Nasal Powder for Nose-to-Brain Delivery of a Neuro-Active SteroidJohns Hopkins University
Lily Zhu
Design, Development, and Validation of a Novel Dry Powder Inhaler Adaptor for Increased Deposition of Anti-Inflammatory Agents in Pediatric AsthmaKiel University
Melvin Wostry
Optimization of Carrier Particle Geometry for Enhanced Inhalation Performance by Parametric DesignOliver Ingham
An Evaluation of Extractable Levels from Various Polybutylene Terephthalate Supplies in the Presence of Ethanol in Formulations Containing HFA-152a and HFO-1234zeAaron Taylor
Understanding Drug Deposition in USP and OPCM Throats for HFA-152a Solution pMDIsLakehead University
Mahsa Jahed
Effects of Airway Wall Dynamics During Inhalation on Drug Delivery via Pressurized Metered Dose Inhalers Using Patient-Specific Airway ModelsLakehead University
Mona Mohammadkhani
Enhancing the Efficiency of pMDIs Through an Innovative Mesh Grid DesignCamille Dumont
Selection of the Best Capsule Type to Maximize the Performance of a Model Carrier-Based Dry Powder Inhalation FormulationCameron Kadleck
Spray Dried Lipid Nanoparticles for Intranasal Delivery
EOBeatriz Noriega Fernandes and Emily Osborne
Fine-Tuning Spray-Dried Inhalable Powders: Impact of Component Saturation on PerformanceLudwig-Maximilians-University Munich
Leonie Deßloch
Inhalable Spray Dried Lipid Nanoparticles for Pulmonary siRNA DeliveryLund University
Kyrre Thalberg
The Role of Carrier Particle Size in Adhesive Mixtures for InhalationVaishnavi Kapileshwari and Mridul Majumder
Predicting Blend Performance of a Dry Powder Inhalation Formulation Using Raman SpectroscopyMacquarie University
Chun Yuen Jerry Wong
Optimizing Intranasal Delivery of Peptides for Targeted Brain Drug Delivery in Transgenic Mouse Models of Alzheimer’s DiseaseMonash University
Tuncay Alan
Ultrasonically Actuated Platform Integrating a Drug-Loaded Cartridge with Microfluidics: Delivering High-Viscosity Solutions with Adjustable Flow RatesMonash University
Michael Pangestu
Experimental Investigation of the Air and Droplet Dynamics of a Soft Mist InhalerReanne Beaird
Assessment of the Semi-Automatic Filling of UDS-P Device with Engineered Powders for Nasal DeliveryLucas Silva
The Impact of Excipients and Spray Drying on Improving the Permeability of Spray-Dried Leuprolide Formulations Using RPMI-2650 CellsLucas Silva
The Impact of OrbitalTM Device Puck Configurations on the Deposition of Itraconazole Nebu~Flow
Sarina Saeidi
Novel Method for Sized Aerosol Sampling in the Characterization of Nebulized BiologicsNebu~Flow
David Tatnell
A New Nebulizer Architecture Using Coupling Layer-free Superstrates Allows Easier Cleaning and Better Performance Over TimeNebu~Flow
Kiing Seng Wong
An Acoustic Nebulizer Platform for Aerosolization of BiologicsSteve Flaherty
An Assessment of the Potential Manufacturing Scale Flammability of Low Global Warming Potential FormulationsJames Murray
Assessment of Suspension Characteristics of Budesonide Micronized by Traditional Jet Milling and by Sonocrystallization Suspended in High and Low Global Warming PropellantsOrexo AB
Jonas Sävmarker
Novel Spray Dried Nasal Powder of Eletriptan: In Vitro and Pre-Clinical In Vivo StudiesDavid Lewis
Plume Temperature: HFA-134a & HFA-227ea Compared to Low GWP Propellants HFA-152a & HFO-1234zeAndrea Winzen
Correlation of Leakage and Aerosol Performance Measurement for Five Valved Holding Chambers with Pediatric FacemasksSummer Hancock
The Importance of Shear Thinning for High Viscosity Nasal SuspensionsIain Ross
Advancing Cleaning and Disinfection Standards for Mesh Nebulizers: A Patient-Centric Study Introducing Zerowater®Philip Smith
Simplified Mechanism Modelling: Optimizing a Dry Powder Inhaler for Ease of UsePolitecnico di Torino
Lorena Pasero
Spray Freeze-Drying Inhalable Powders of a Monoclonal Antibody: The Role of Formulation in Achieving Stability and FlowabilityPolitecnico di Torino
Lorena Pasero
The Influence of Freezing, Storage, and Formulation on Mannitol Polymorphism and Powder Deposition after Spray Freeze-DryingRIGImmune
Jag Shur
Modelling the Impact of Mucoadhesive Formulations on Intranasal Delivery of RIG-101, a Stem-Loop Ribonucleic Acid TherapeuticRIGImmune
Jag Shur
Refining Regional Deposition Predictions in Metered Dose Inhalers: A Comparison of Static and Dynamic ICRP ModelsYannick Baschung
Evaluating Critical Handling Errors in Inhalation Devices: The Role of Tailored In Vitro TestingTherakind Limited
Julie-Ann Penton
Development of a Particle Engineered Aspirin Powder for Intranasal Delivery: Evaluating Delivery Performance from a Novel Intranasal DeviceMark Nagel and Jolyon Mitchell
Inhaled Maintenance and Reliever Therapy and Anti-Inflammatory-Reliever Therapy: Exploring In Vitro Performance of a Portable Valved Holding ChamberJason Suggett
Clinical Evaluation of a Prototype Smart Valved Holding Chamber to Monitor and Improve Adherence to Metered Dose Inhaler MedicationUniversity of Hertfordshire
Darragh Murnane
Pre-Actuation Microstructure Within Dry Powder Inhaler Blisters Revealed Through X-Ray Computed TomographyUniversity of Hertfordshire
Lois Slator
Assessing Fitness-for-Purpose to Support Clinical Application of an Adaptive Breath-Actuated NebulizerUniversity of Hertfordshire
Giorgia Vaccaro and Darragh Murnane
Development of a Single Actuation Impaction Method for Aerosolization Assessment of Soft Mist Inhalers: Comparison for MRX004 and Respimat®University of Leeds
Benjamin Mignot
Influence of Viscosity and Surface Tension on Droplet Size Distribution and Plume Characteristics of the Respimat® Soft Mist InhalerUniversity of Limerick
Aoife Cotter
Development of a Dry Powder Formulation of Deoxyribonuclease I using Spray DryingStefania Glieca and Irene Rossi
Bulk Excipient Screening of a Spray Dried Glucagon-Like Peptide 1 Receptor Agonist FormulationStefania Glieca
Lactobacilli Inhalation Powders as Antibacterial Agents Against S. AureusUniversity of Toronto
Peter Di Palma
A Comparison of Particle Dynamics Within Several Airway Models Using Phase Doppler AnemometryRaneem Aldaqqa
Leveraging Chemo-Immunotherapy to Remodel the Tumor Microenvironment and Enhance Treatment Efficacy in Osteosarcoma Lung MetastasesRudra Pangeni and Michael Hindle
In Vivo Deposition and Retention of Ciprofloxacin Liposomal Dry Powder AerosolWoolcock Institute of Medical Research
Patrick He
Evaluation of the Resyca® PFSI™ Soft Mist Inhaler for Efficient Delivery of mRNA-lipid Nanoparticles to the LungsWorld Medicine
Gozde Fidan and Sulenur Ekmekci
Comparison of Solution and Suspension Nasal Spray Formulations by Laser Diffraction and Next Generation Impactor Methods
Questions?
For further information, contact Richard Dalby.